83 FR 2671 - Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 12 (January 18, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 12 (January 18, 2018)
| Page Range | 2671-2675 | |
| FR Document | 2018-00710 |
[Federal Register Volume 83, Number 12 (Thursday, January 18, 2018)] [Notices] [Pages 2671-2675] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-00710] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 19, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. [[Page 2672]] SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on October 23, 2017, Chemtos, LLC, 14101 W. Highway 290, Building 2000B, Austin, Texas 78737-9331 applied to be registered as a bulk manufacturer for the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ 3-Fluoro-N-methylcathinone (3-FMC). 1233 I Cathinone.......................... 1235 I Methcathinone...................... 1237 I 4-Fluoro-N-methylcathinone (4-FMC). 1238 I Pentedrone ([alpha]- 1246 I methylaminovalerophenone). Mephedrone (4-Methyl-N- 1248 I methylcathinone). 4-Methyl-N-ethylcathinone (4-MEC).. 1249 I Naphyrone.......................... 1258 I N-Ethylamphetamine................. 1475 I N,N-Dimethylamphetamine............ 1480 I Fenethylline....................... 1503 I Aminorex........................... 1585 I 4-Methylaminorex (cis isomer)...... 1590 I Gamma Hydroxybutyric Acid.......... 2010 I Methaqualone....................... 2565 I Mecloqualone....................... 2572 I JWH-250 (1-Pentyl-3-(2- 6250 I methoxyphenylacetyl) indole). SR-18 (Also known as RCS-8) (1- 7008 I Cyclohexylethyl-3-(2- methoxyphenylacetyl) indole). ADB-FUBINACA (N-(1-amino-3,3- 7010 I dimethyl-1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole-3- carboxamide). 5-Fluoro-UR-144 and XLR11 [1-(5- 7011 I Fluoro-pentyl)1H-indol-3- yl](2,2,3,3- tetramethylcyclopropyl)methanone. AB-FUBINACA (N-(1-amino-3-methyl-1- 7012 I oxobutan-2-yl)-1-(4-fluorobenzyl)- 1H-indazole-3-carboxamide). JWH-019 (1-Hexyl-3-(1- 7019 I naphthoyl)indole). MDMB-FUBINACA (Methyl 2-(1-(4- 7020 I fluorobenzyl)-1H-indazole-3- carboxamido)-3,3- dimethylbutanoate). AB-PINACA (N-(1-amino-3-methyl-1- 7023 I oxobutan-2-yl)-1-pentyl-1H- indazole-3-carboxamide). THJ-2201 [1-(5-fluoropentyl)-1H- 7024 I indazol-3-yl](naphthalen-1- yl)methanone. AB-CHMINACA (N-(1-amino-3-methyl-1- 7031 I oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3- carboxamide. MAB-CHMINACA (N-(1-amino- 7032 I 3,3dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3- carboxamide). 5F-AMB (Methyl 2-(1-(5- 7033 I fluoropentyl)-1H-indazole-3- carboxamido)-3-methylbutanoate). 5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1- 7034 I (5-fluoropentyl)-1H-indazole-3- carboxamido)-3,3- dimethylbutanoate). ADB-PINACA (N-(1-amino-3,3-dimethyl- 7035 I 1-oxobutan-2-yl)-1-pentyl-1H- indazole-3-carboxamide). MDMB-CHMICA, MMB-CHMINACA (Methyl 2- 7042 I (1-(cyclohexylmethyl)-1H-indole-3- carboxamido)-3,3- dimethylbutanoate). APINACA and AKB48 N-(1-Adamantyl)-1- 7048 I pentyl-1H-indazole-3-carboxamide. 5F-APINACA, 5F-AKB48 (N-(adamantan- 7049 I 1-yl)-1-(5-fluoropentyl)-1H- indazole-3-carboxamide). JWH-081 (1-Pentyl-3-(1-(4- 7081 I methoxynaphthoyl) indole). SR-19 (Also known as RCS-4) (1- 7104 I Pentyl-3-[(4-methoxy)-benzoyl] indole. JWH-018 (also known as AM678) (1- 7118 I Pentyl-3-(1-naphthoyl)indole). JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I naphthoyl) indole). UR-144 (1-Pentyl-1H-indol-3- 7144 I yl)(2,2,3,3- tetramethylcyclopropyl)methanone. JWH-073 (1-Butyl-3-(1- 7173 I naphthoyl)indole). JWH-200 (1-[2-(4-Morpholinyl)ethyl]- 7200 I 3-(1-naphthoyl)indole). AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I naphthoyl) indole). JWH-203 (1-Pentyl-3-(2- 7203 I chlorophenylacetyl) indole). PB-22 (Quinolin-8-yl 1-pentyl-1H- 7222 I indole-3-carboxylate). 5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I fluoropentyl)-1H-indole-3- carboxylate). Alpha-ethyltryptamine.............. 7249 I Ibogaine........................... 7260 I CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I [(1R,3S)-3-hydroxycyclohexyl- phenol). CP-47,497 C8 Homologue (5-(1,1- 7298 I Dimethyloctyl)-2-[(1R,3S)3- hydroxycyclohexyl-phenol). Lysergic acid diethylamide......... 7315 I 2,5-Dimethoxy-4-(n)- 7348 I propylthiophenethylamine (2C-T-7). Marihuana Extract.................. 7350 I Marihuana.......................... 7360 I Tetrahydrocannabinols.............. 7370 I Parahexyl.......................... 7374 I Mescaline.......................... 7381 I 2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I ethanamine (2C-T-2). 3,4,5-Trimethoxyamphetamine........ 7390 I 4-Bromo-2,5-dimethoxyamphetamine... 7391 I 4-Bromo-2,5-dimethoxyphenethylamine 7392 I 4-Methyl-2,5-dimethoxyamphetamine.. 7395 I 2,5-Dimethoxyamphetamine........... 7396 I [[Page 2673]] JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I naphthoyl) indole). 2,5-Dimethoxy-4-ethylamphetamine... 7399 I 3,4-Methylenedioxyamphetamine...... 7400 I 5-Methoxy-3,4- 7401 I methylenedioxyamphetamine. N-Hydroxy-3,4- 7402 I methylenedioxyamphetamine. 3,4-Methylenedioxy-N- 7404 I ethylamphetamine. 3,4-Methylenedioxymethamphetamine.. 7405 I 4-Methoxyamphetamine............... 7411 I 5-Methoxy-N-N-dimethyltryptamine... 7431 I Alpha-methyltryptamine............. 7432 I Bufotenine......................... 7433 I Diethyltryptamine.................. 7434 I Dimethyltryptamine................. 7435 I Psilocybin......................... 7437 I Psilocyn........................... 7438 I 5-Methoxy-N,N-diisopropyltryptamine 7439 I N-Ethyl-1-phenylcyclohexylamine.... 7455 I 1-(1-Phenylcyclohexyl)pyrrolidine.. 7458 I 1-[1-(2- 7470 I Thienyl)cyclohexyl]piperidine. 1-[1-(2- 7473 I Thienyl)cyclohexyl]pyrrolidine. N-Ethyl-3-piperidyl benzilate...... 7482 I N-Methyl-3-piperidyl benzilate..... 7484 I N-Benzylpiperazine................. 7493 I 4-Methyl- 7498 I alphapyrrolidinopropiophenone (4- MePPP). 2-(2,5-Dimethoxy-4-methylphenyl) 7508 I ethanamine (2C-D). 2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I ethanamine (2C-E ). 2-(2,5-Dimethoxyphenyl) ethanamine 7517 I (2C-H). 2-(4-iodo-2,5-dimethoxyphenyl) 7518 I ethanamine (2C-I). 2-(4-Chiara-2,5-dimethoxyphenyl) 7519 I ethanamine (2C-C). 2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I ethanamine (2C-N). 2-(2,5-Dimethoxy-4-(n)- 7524 I propylphenyl) ethanamine (2C-P). 2-(4-Isopropylthio)-2,5- 7532 I dimethoxyphenyl) ethanamine (2C-T- 4). MDPV (3,4- 7535 I Methylenedioxypyrovalerone). 2-(4-bromo-2,5-dimethoxyphenyl)-N- 7536 I (2-methoxybenzyl) ethanamine (25B- NBOMe). 2-(4-chloro-2,5-dimethoxyphenyl)-N- 7537 I (2-methoxybenzyl) ethanamine (25C- NBOMe). 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I methoxybenzyl) ethanamine (25I- NBOMe). Methylone (3,4-Methylenedioxy-N- 7540 I methylcathinone). Butylone........................... 7541 I Pentylone.......................... 7542 I alpha-pyrrolidinopentiophenone 7545 I ([alpha]-PVP). alpha-pyrrolidinobutiophenone 7546 I ([alpha]-PBP). AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I iodobenzoyl) indole). Acetyldihydrocodeine............... 9051 I Benzylmorphine..................... 9052 I Codeine-N-oxide.................... 9053 I Cyprenorphine...................... 9054 I Desomorphine....................... 9055 I Etorphine (except HCl)............. 9056 I Codeine methylbromide.............. 9070 I Dihydromorphine.................... 9145 I Difenoxin.......................... 9168 I Heroin............................. 9200 I Hydromorphinol..................... 9301 I Methyldesorphine................... 9302 I Methyldihydromorphine.............. 9304 I Morphine methylbromide............. 9305 I Morphine methylsulfonate........... 9306 I Morphine-N-oxide................... 9307 I Myrophine.......................... 9308 I Nicocodeine........................ 9309 I Nicomorphine....................... 9312 I Normorphine........................ 9313 I Pholcodine......................... 9314 I Thebacon........................... 9315 I Acetorphine........................ 9319 I Drotebanol......................... 9335 I U-47700 (3,4-dichloro-N-[2- 9547 I (dimethylamino)cyclohexyl]-N- methylbenzamide). AH-7921 (3,4-dichloro-N-[(1- 9551 I dimethylamino)cyclohexylmethyl]ben zamide)). Acetylmethadol..................... 9601 I Allylprodine....................... 9602 I Alphacetylmethadol except levo- 9603 I alphacetylmethadol. Alphameprodine..................... 9604 I Alphamethadol...................... 9605 I Benzethidine....................... 9606 I [[Page 2674]] Betacetylmethadol.................. 9607 I Betameprodine...................... 9608 I Betamethadol....................... 9609 I Betaprodine........................ 9611 I Clonitazene........................ 9612 I Dextromoramide..................... 9613 I Diampromide........................ 9615 I Diethylthiambutene................. 9616 I Dimenoxadol........................ 9617 I Dimepheptanol...................... 9618 I Dimethylthiambutene................ 9619 I Dioxaphetyl butyrate............... 9621 I Dipipanone......................... 9622 I Ethylmethylthiambutene............. 9623 I Etonitazene........................ 9624 I Etoxeridine........................ 9625 I Furethidine........................ 9626 I Hydroxypethidine................... 9627 I Ketobemidone....................... 9628 I Levomoramide....................... 9629 I Levophenacylmorphan................ 9631 I Morpheridine....................... 9632 I Noracymethadol..................... 9633 I Norlevorphanol..................... 9634 I Normethadone....................... 9635 I Norpipanone........................ 9636 I Phenadoxone........................ 9637 I Phenampromide...................... 9638 I Phenoperidine...................... 9641 I Piritramide........................ 9642 I Proheptazine....................... 9643 I Properidine........................ 9644 I Racemoramide....................... 9645 I Trimeperidine...................... 9646 I Phenomorphan....................... 9647 I Propiram........................... 9649 I 1-Methyl-4-phenyl-4- 9661 I propionoxypiperidine. 1-(2-Phenylethyl)-4-phenyl-4- 9663 I acetoxypiperidine. Tilidine........................... 9750 I Acryl fentanyl (N-(1- 9811 I phenethylpiperidin-4-yl)-N- phenylacrylamide). Para-Fluorofentanyl................ 9812 I 3-Methylfentanyl................... 9813 I Alpha-methylfentanyl............... 9814 I Acetyl-alpha-methylfentanyl........ 9815 I Acetyl Fentanyl (N-(1- 9821 I phenethylpiperidin-4-yl)-N- phenylacetamide). Butyryl Fentanyl................... 9822 I 4-Fluoroisobutyryl fentanyl (N-(4- 9824 I fluorophenyl)-N-(1- phenethylpiperidin-4- yl)isobutyramide). Beta-hydroxyfentanyl............... 9830 I Beta-hydroxy-3-methylfentanyl...... 9831 I Alpha-methylthiofentanyl........... 9832 I 3-Methylthiofentanyl............... 9833 I Furanyl fentanyl (N-(1- 9834 I phenethylpiperidin-4-yl)-N- phenylfuran-2-carboxamide). Thiofentanyl....................... 9835 I Beta-hydroxythiofentanyl........... 9836 I Amphetamine........................ 1100 II Methamphetamine.................... 1105 II Lisdexamfetamine................... 1205 II Phenmetrazine...................... 1631 II Methylphenidate.................... 1724 II Amobarbital........................ 2125 II Pentobarbital...................... 2270 II Secobarbital....................... 2315 II Glutethimide....................... 2550 II Nabilone........................... 7379 II 1-Phenylcyclohexylamine............ 7460 II Phencyclidine...................... 7471 II 4-Anilino-N-phenethyl-4-piperidine 8333 II (ANPP). Phenylacetone...................... 8501 II 1-Piperidinocyclohexanecarbonitrile 8603 II Alphaprodine....................... 9010 II Anileridine........................ 9020 II Cocaine............................ 9041 II Codeine............................ 9050 II Etorphine HCI...................... 9059 II [[Page 2675]] Dihydrocodeine..................... 9120 II Oxycodone.......................... 9143 II Hydromorphone...................... 9150 II Diphenoxylate...................... 9170 II Ecgonine........................... 9180 II Ethylmorphine...................... 9190 II Hydrocodone........................ 9193 II Levomethorphan..................... 9210 II Levorphanol........................ 9220 II Isomethadone....................... 9226 II Meperidine......................... 9230 II Meperidine intermediate-A.......... 9232 II Meperidine intermediate-B.......... 9233 II Meperidine intermediate-C.......... 9234 II Methadone.......................... 9250 II Methadone intermediate............. 9254 II Metopon............................ 9260 II Dextropropoxyphene, bulk (non- 9273 II dosage forms). Morphine........................... 9300 II Thebaine........................... 9333 II Dihydroetorphine................... 9334 II Levo-alphacetylmethadol............ 9648 II Oxymorphone........................ 9652 II Noroxymorphone..................... 9668 II Phenazocine........................ 9715 II Thiafentanil....................... 9729 II Piminodine......................... 9730 II Racemethorphan..................... 9732 II Racemorphan........................ 9733 II Alfentanil......................... 9737 II Remifentanil....................... 9739 II Sufentanil......................... 9740 II Carfentanil........................ 9743 II Tapentadol......................... 9780 II Bezitramide........................ 9800 II Fentanyl........................... 9801 II Moramide-intermediate.............. 9802 II ------------------------------------------------------------------------ The company plans to manufacture small quantities of the listed controlled substances in bulk for distribution to its customers. Dated: January 5, 2018. Susan A. Gibson, Deputy Assistant Administrator. [FR Doc. 2018-00710 Filed 1-17-18; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 83, No. 12 / Thursday, January 18, 2018 / Notices 2671
205–2737. Copies of non-confidential No public interest comments were Commission should grant such
documents filed in connection with this received from the public. treatment. See 19 CFR 201.6. Documents
investigation are or will be available for Having examined the record of this for which confidential treatment by the
inspection during official business investigation, including the ALJ’s final Commission is properly sought will be
hours (8:45 a.m. to 5:15 p.m.) in the ID, the petitions for review, and the treated accordingly. All information,
Office of the Secretary, U.S. responses thereto, the Commission has including confidential business
International Trade Commission, 500 E determined to review-in-part the final information and documents for which
Street SW, Washington, DC 20436, ID. Specifically, the Commission has confidential treatment is properly
telephone (202) 205–2000. General determined to review the ID’s findings sought, submitted to the Commission for
information concerning the Commission on (1) standing, (2) infringement, (3) purposes of this Investigation may be
may also be obtained by accessing its invalidity, (4) inequitable conduct, and disclosed to and used: (i) By the
internet server at https://www.usitc.gov. (5) domestic industry. Commission, its employees and Offices,
The public record for this investigation The parties are invited to brief their and contract personnel (a) for
may be viewed on the Commission’s responses to the following question developing or maintaining the records
electronic docket (EDIS) at https:// only, with reference to the applicable of this or a related proceeding, or (b) in
edis.usitc.gov. Hearing-impaired law and the evidentiary record. internal investigations, audits, reviews,
persons are advised that information on 1. Is a determination on whether a licensee and evaluations relating to the
this matter can be obtained by is subject to an exclusive license necessary to programs, personnel, and operations of
contacting the Commission’s TDD reach the ‘‘all substantial rights’’ analysis? the Commission including under 5
terminal on (202) 205–1810. Are the factors set forth in Azure Networks, U.S.C. Appendix 3; or (ii) by U.S.
LLC v. CSR PLC, 771 F.3d 1336 (Fed. Cir. government employees and contract
SUPPLEMENTARY INFORMATION: The 2014), judgment vacated on other grounds,
personnel, solely for cybersecurity
Commission instituted this investigation CSR PLC et.al. v. Azure Networks, 135 S. Ct.
1846, 2015 W1 582818 (Apr. 20, 2015), purposes. All contract personnel will
on October 25, 2016, based on a sign appropriate nondisclosure
complaint filed by Andrea Electronics relevant to the question of standing raised in
this investigation? agreements. All non-confidential
Corp. of Bohemia, New York written submissions will be available for
(‘‘Andrea’’). 81 FR 73418 (Oct. 25, The parties are not to brief other
issues on review, which are adequately public inspection at the Office of the
2016). The complaint alleges violations Secretary and on EDIS.
of section 337 by reason of infringement presented in the parties’ existing filings.
At this time, the Commission is not The authority for the Commission’s
of certain claims of U.S. Patent No. determination is contained in section
6,049,607 (‘‘the ’607 patent’’), U.S. requesting written submissions on
remedy, public interest, or bonding. 337 of the Tariff Act of 1930, as
Patent No. 6,363,345 (‘‘the ’345 patent’’), amended, 19 U.S.C. 1337, and in Part
and U.S. Patent No. 6,377,637 (‘‘the ’637 Written Submissions: Each party’s
written submission responding to the 210 of the Commission’s Rules of
patent’’). The Commission’s notice of Practice and Procedure, 19 CFR part
investigation named the following above questions and any response to the
initial submissions should be no more 210.
respondents: Apple Inc. of Cupertino,
California (‘‘Apple’’); and Samsung than 20 pages. The written submissions By order of the Commission.
Electronics Co., Ltd. of Gyeonggi-do, must be filed no later than close of Issued: January 11, 2018.
Republic of Korea, and Samsung business on Wednesday, January 24, Lisa R. Barton,
Electronics America, Inc. of Ridgefield 2018. Reply submissions must be filed Secretary to the Commission.
Park, New Jersey (collectively, no later than the close of business on [FR Doc. 2018–00736 Filed 1–17–18; 8:45 am]
‘‘Samsung’’). The Office of Unfair Wednesday, January 31, 2018. No BILLING CODE P
Import Investigations (‘‘OUII’’) is also a further submissions on these issues will
party in this investigation. Samsung was be permitted unless otherwise ordered
previously terminated from the by the Commission.
investigation. All asserted claims of the Persons filing written submissions DEPARTMENT OF JUSTICE
’607 and ’637 patents were also must file the original document
previously terminated from the electronically on or before the deadlines Drug Enforcement Administration
investigation. stated above and submit 8 true paper
copies to the Office of the Secretary by [Docket No. DEA–392]
On October 26, 2017, the ALJ issued noon the next day pursuant to
her final ID finding no violation of Commission Rule 210.4(f), 19 CFR Bulk Manufacturer of Controlled
section 337 by Apple for the ’345 patent. 210.4(f). Submissions should refer to the Substances Application: Chemtos,
Specifically, the final ID found that investigation number (‘‘Inv. No. 1026’’) LLC
Andrea does not have standing to assert in a prominent place on the cover page
the ’345 patent, the accused products do and/or the first page. (See Handbook for ACTION: Notice of application.
not infringe the ’345 patent, and Andrea Electronic Filing Procedures,https://
has not met the domestic industry www.usitc.gov/secretary/documents/ DATES: Registered bulk manufacturers of
requirements. handbook_on_filing_procedures.pdf). the affected basic classes, and
On November 8, 2017, Andrea and Persons with questions regarding filing applicants therefore, may file written
OUII each filed timely petitions for should contact the Secretary, (202) 205– comments on or objections to the
review of the final ID. That same day, issuance of the proposed registration on
sradovich on DSK3GMQ082PROD with NOTICES
2000.
Apple filed a contingent petition for Any person desiring to submit a or before March 19, 2018.
review of the final ID. On November 16, document to the Commission in ADDRESSES: Written comments should
2017, the parties each filed a timely confidence must request confidential be sent to: Drug Enforcement
response to the petitions for review. On treatment. All such requests should be Administration, Attention: DEA Federal
November 27, 2017, the private parties directed to the Secretary to the Register Representative/DRW, 8701
filed their public interest comments Commission and must include a full Morrissette Drive, Springfield, Virginia
pursuant to Commission Rule 210.50. statement of the reasons why the 22152.
VerDate Sep<11>2014 18:27 Jan 17, 2018 Jkt 244001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\18JAN1.SGM 18JAN1](https://thefederalregister.org/doc/83_FR_2683/page/1.svg)
methanone ................ 7011 I
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..................... 7012 I
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ...................................................................................................................... 7019 I
MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...................... 7020 I
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................................... 7023 I
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ................................................................... 7024 I
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ................. 7031 I
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ........ 7032 I
5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .............................................. 7033 I
5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...... 7034 I
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................. 7035 I
MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3- 7042 I
dimethylbutanoate).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .............................................................. 7048 I
5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) .................................. 7049 I
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .................................................................................................. 7081 I
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole .................................................................... 7104 I
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. 7118 I
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ..................................................................................................... 7122 I
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ................................................................. 7144 I
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ....................................................................................................................... 7173 I
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .......................................................................................... 7200 I
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ....................................................................................................... 7201 I
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... 7203 I
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ................................................................................................. 7222 I
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ............................................................................ 7225 I
Alpha-ethyltryptamine ...................................................................................................................................................... 7249 I
Ibogaine ........................................................................................................................................................................... 7260 I
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................ 7297 I
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .......................................... 7298 I
Lysergic acid diethylamide .............................................................................................................................................. 7315 I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) .............................................................................................. 7348 I
Marihuana Extract ........................................................................................................................................................... 7350 I
Marihuana ........................................................................................................................................................................ 7360 I
Tetrahydrocannabinols .................................................................................................................................................... 7370 I
sradovich on DSK3GMQ082PROD with NOTICES
Parahexyl ......................................................................................................................................................................... 7374 I
Mescaline ......................................................................................................................................................................... 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2) ........................................................................................... 7385 I
3,4,5-Trimethoxyamphetamine ........................................................................................................................................ 7390 I
4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 7391 I
4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 7392 I
4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 7395 I
2,5-Dimethoxyamphetamine ............................................................................................................................................ 7396 I
VerDate Sep<11>2014 18:27 Jan 17, 2018 Jkt 244001 PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 E:\FR\FM\18JAN1.SGM 18JAN1](https://thefederalregister.org/doc/83_FR_2683/page/2.svg)
![Federal Register / Vol. 83, No. 12 / Thursday, January 18, 2018 / Notices 2673
Controlled substance Drug code Schedule
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 7398 I
2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................ 7399 I
3,4-Methylenedioxyamphetamine .................................................................................................................................... 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7402 I
3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 7404 I
3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I
4-Methoxyamphetamine .................................................................................................................................................. 7411 I
5-Methoxy-N-N-dimethyltryptamine ................................................................................................................................. 7431 I
Alpha-methyltryptamine ................................................................................................................................................... 7432 I
Bufotenine ........................................................................................................................................................................ 7433 I
Diethyltryptamine ............................................................................................................................................................. 7434 I
Dimethyltryptamine .......................................................................................................................................................... 7435 I
Psilocybin ......................................................................................................................................................................... 7437 I
Psilocyn ........................................................................................................................................................................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. 7439 I
N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................... 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................... 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... 7470 I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine .............................................................................................................................. 7473 I
N-Ethyl-3-piperidyl benzilate ............................................................................................................................................ 7482 I
N-Methyl-3-piperidyl benzilate ......................................................................................................................................... 7484 I
N-Benzylpiperazine .......................................................................................................................................................... 7493 I
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ..................................................................................................... 7498 I
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) .................................................................................................. 7508 I
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) .................................................................................................... 7509 I
2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) ................................................................................................................. 7517 I
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ........................................................................................................ 7518 I
2-(4-Chiara-2,5-dimethoxyphenyl) ethanamine (2C–C) .................................................................................................. 7519 I
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) .................................................................................................... 7521 I
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) ............................................................................................. 7524 I
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4) .................................................................................... 7532 I
MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 7535 I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) .................................................... 7536 I
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) .................................................... 7537 I
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) ......................................................... 7538 I
Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... 7540 I
Butylone ........................................................................................................................................................................... 7541 I
Pentylone ......................................................................................................................................................................... 7542 I
alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................ 7545 I
alpha-pyrrolidinobutiophenone (a-PBP) .......................................................................................................................... 7546 I
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ................................................................................................... 7694 I
Acetyldihydrocodeine ....................................................................................................................................................... 9051 I
Benzylmorphine ............................................................................................................................................................... 9052 I
Codeine-N-oxide .............................................................................................................................................................. 9053 I
Cyprenorphine ................................................................................................................................................................. 9054 I
Desomorphine ................................................................................................................................................................. 9055 I
Etorphine (except HCl) .................................................................................................................................................... 9056 I
Codeine methylbromide ................................................................................................................................................... 9070 I
Dihydromorphine ............................................................................................................................................................. 9145 I
Difenoxin .......................................................................................................................................................................... 9168 I
Heroin .............................................................................................................................................................................. 9200 I
Hydromorphinol ............................................................................................................................................................... 9301 I
Methyldesorphine ............................................................................................................................................................ 9302 I
Methyldihydromorphine ................................................................................................................................................... 9304 I
Morphine methylbromide ................................................................................................................................................. 9305 I
Morphine methylsulfonate ............................................................................................................................................... 9306 I
Morphine-N-oxide ............................................................................................................................................................ 9307 I
Myrophine ........................................................................................................................................................................ 9308 I
Nicocodeine ..................................................................................................................................................................... 9309 I
Nicomorphine ................................................................................................................................................................... 9312 I
Normorphine .................................................................................................................................................................... 9313 I
Pholcodine ....................................................................................................................................................................... 9314 I
Thebacon ......................................................................................................................................................................... 9315 I
Acetorphine ...................................................................................................................................................................... 9319 I
Drotebanol ....................................................................................................................................................................... 9335 I
sradovich on DSK3GMQ082PROD with NOTICES
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .............................................................. 9547 I
AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .................................................................. 9551 I
Acetylmethadol ................................................................................................................................................................ 9601 I
Allylprodine ...................................................................................................................................................................... 9602 I
Alphacetylmethadol except levo-alphacetylmethadol ...................................................................................................... 9603 I
Alphameprodine ............................................................................................................................................................... 9604 I
Alphamethadol ................................................................................................................................................................. 9605 I
Benzethidine .................................................................................................................................................................... 9606 I
VerDate Sep<11>2014 18:27 Jan 17, 2018 Jkt 244001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\18JAN1.SGM 18JAN1](https://thefederalregister.org/doc/83_FR_2683/page/3.svg)
![Federal Register / Vol. 83, No. 12 / Thursday, January 18, 2018 / Notices 2675
Controlled substance Drug code Schedule
Dihydrocodeine ................................................................................................................................................................ 9120 II
Oxycodone ....................................................................................................................................................................... 9143 II
Hydromorphone ............................................................................................................................................................... 9150 II
Diphenoxylate .................................................................................................................................................................. 9170 II
Ecgonine .......................................................................................................................................................................... 9180 II
Ethylmorphine .................................................................................................................................................................. 9190 II
Hydrocodone ................................................................................................................................................................... 9193 II
Levomethorphan .............................................................................................................................................................. 9210 II
Levorphanol ..................................................................................................................................................................... 9220 II
Isomethadone .................................................................................................................................................................. 9226 II
Meperidine ....................................................................................................................................................................... 9230 II
Meperidine intermediate-A .............................................................................................................................................. 9232 II
Meperidine intermediate-B .............................................................................................................................................. 9233 II
Meperidine intermediate-C .............................................................................................................................................. 9234 II
Methadone ....................................................................................................................................................................... 9250 II
Methadone intermediate .................................................................................................................................................. 9254 II
Metopon ........................................................................................................................................................................... 9260 II
Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. 9273 II
Morphine .......................................................................................................................................................................... 9300 II
Thebaine .......................................................................................................................................................................... 9333 II
Dihydroetorphine ............................................................................................................................................................. 9334 II
Levo-alphacetylmethadol ................................................................................................................................................. 9648 II
Oxymorphone .................................................................................................................................................................. 9652 II
Noroxymorphone ............................................................................................................................................................. 9668 II
Phenazocine .................................................................................................................................................................... 9715 II
Thiafentanil ...................................................................................................................................................................... 9729 II
Piminodine ....................................................................................................................................................................... 9730 II
Racemethorphan ............................................................................................................................................................. 9732 II
Racemorphan .................................................................................................................................................................. 9733 II
Alfentanil .......................................................................................................................................................................... 9737 II
Remifentanil ..................................................................................................................................................................... 9739 II
Sufentanil ......................................................................................................................................................................... 9740 II
Carfentanil ....................................................................................................................................................................... 9743 II
Tapentadol ....................................................................................................................................................................... 9780 II
Bezitramide ...................................................................................................................................................................... 9800 II
Fentanyl ........................................................................................................................................................................... 9801 II
Moramide-intermediate .................................................................................................................................................... 9802 II
The company plans to manufacture Administration, Attention: DEA Federal of thebaine (9333), a basic class of
small quantities of the listed controlled Register Representative/DRW, 8701 controlled substance listed in schedule
substances in bulk for distribution to its Morrissette Drive, Springfield, Virginia II.
customers. 22152. The company states they plan to
Dated: January 5, 2018. SUPPLEMENTARY INFORMATION: The conduct clinical trials.
Susan A. Gibson, Attorney General has delegated his Dated: January 5, 2018.
Deputy Assistant Administrator. authority under the Controlled Susan A. Gibson,
[FR Doc. 2018–00710 Filed 1–17–18; 8:45 am] Substances Act to the Administrator of Deputy Assistant Administrator.
BILLING CODE 4410–09–P the Drug Enforcement Administration [FR Doc. 2018–00709 Filed 1–17–18; 8:45 am]
(DEA), 28 CFR 0.100(b). Authority to
BILLING CODE 4410–09–P
exercise all necessary functions with
DEPARTMENT OF JUSTICE respect to the promulgation and
implementation of 21 CFR part 1301, DEPARTMENT OF JUSTICE
Drug Enforcement Administration incident to the registration of
[Docket No. DEA–392] manufacturers, distributors, dispensers, Notice of Proposed Settlement
importers, and exporters of controlled Agreement Under the Oil Pollution Act
Bulk Manufacturer of Controlled substances (other than final orders in
Substances Application: Alcami connection with suspension, denial, or On January 9, 2018, a fully-executed
Wisconsin Corporation revocation of registration) has been proposed Settlement Agreement was
redelegated to the Assistant received by the Department of Justice,
ACTION: Notice of application. Administrator of the DEA Diversion among the United States on behalf of the
Control Division (‘‘Assistant U.S. Department of the Interior, U.S.
DATES: Registered bulk manufacturers of Administrator’’) pursuant to section 7 of Fish and Wildlife Service (‘‘FWS’’), the
sradovich on DSK3GMQ082PROD with NOTICES
the affected basic classes, and 28 CFR part 0, appendix to subpart R. State of Georgia, on behalf of the
applicants therefore, may file written In accordance with 21 CFR Georgia Department of Natural
comments on or objections to the 1301.33(a), this is notice that on July 4, Resources (‘‘GDNR’’), and Fukunaga
issuance of the proposed registration on 2017, Alcami Wisconsin Corporation, Kaiun Co., Ltd., a Japanese company
or before March 19, 2018. W130 N10497 Washington Drive, that was the former operator of the
ADDRESSES: Written comments should Germantown, Wisconsin 53022 applied Motor Vessel Fortune Epoch in
be sent to: Drug Enforcement to be registered as a bulk manufacturer November 2004.
VerDate Sep<11>2014 18:27 Jan 17, 2018 Jkt 244001 PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 E:\FR\FM\18JAN1.SGM 18JAN1](https://thefederalregister.org/doc/83_FR_2683/page/5.svg)
Document Created: 2018-01-18 00:42:14
Document Modified: 2018-01-18 00:42:14
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 19, 2018. | |
| FR Citation | 83 FR 2671 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR